Rinvoq (upadacitinib)
pCPA File Number:
22379
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of adults with active ankylosing spondylitis who have had an inadequate response to a biologic DMARD or when use of those therapies is inadvisable
Sponsor/Manufacturer:
AbbVie Corporation
CADTH Project Number:
SR0759
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable